Add this topic to your myFT Digest for news straight to your inbox
Without Lipitor, the company needs to be driven by new drugs that sell
In the drug industry, it is argued mergers actually inhibit the flow of innovative medicines
Court battles loom as drugmakers’ relationship with doctors comes under scrutiny
Big pharma is a shrinking business
International Edition